Concepedia

Alkylating Agent Therapy

Alkylating Agent Therapy is a pharmacotherapeutic strategy involving the use of cytotoxic agents that selectively target and suppress hyperactive B-cell lineages in glomerular disease by inducing covalent DNA modifications, thereby inhibiting aberrant immune cell proliferation.

352

Publications

20.9K

Citations

1.9K

Authors

646

Institutions

Publications per year

2017–2026

41

Parents

Publications

352

Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells

Takao Kanzawa, Isabelle M. Germano, Tadashi Komata et al. · Cell Death and Differentiation · 2004 · 984 citations

, , +11

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou et al. · New England Journal of Medicine · 2019 · 673 citations · Full text

, , +15

Effects of Treatment on Fertility in Long-Term Survivors of Childhood or Adolescent Cancer

Mulvihill Jj, Connelly Rr, Naughton et al. · New England Journal of Medicine · 1987 · 510 citations

, , +17

Fertility of Male Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

Daniel M. Green, Toana Kawashima, Marilyn Stovall et al. · Journal of Clinical Oncology · 2009 · 468 citations · Full text

, , +14

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

Ronald Reimer, Robert N. Hoover, Joseph F. Fraumeni et al. · New England Journal of Medicine · 1977 · 453 citations

, , +16

1–5 of 352

Authors

1.9K

  1. MC
    Morton Coleman

    Cornell University, United States

    4 publications · 206 citations

    4

    h-index

  2. RA
    Robert A. Kyle

    Mayo Clinic, United States

    4 publications · 374 citations

    4

    h-index

  3. PL
    Pier Luigi Zinzani

    University of Bologna, Italy

    4 publications · 65 citations

    4

    h-index

  4. ME
    Monika E. Hegi

    University of Lausanne, Switzerland

    4 publications · 236 citations

    4

    h-index

  5. EF
    Emil Frei

    Dana-Farber Cancer Institute, United States

    4 publications · 356 citations

    4

    h-index

1–5 of 1.9K

Institutions

646

  1. Dana-Farber Cancer Institute

    Boston, United States

    10 h-index

    47 publications

    4.3K citations

  2. National Cancer Institute

    Bethesda, United States

    10 h-index

    28 publications

    3.3K citations

  3. Memorial Sloan Kettering Cancer Center

    New York, United States

    9 h-index

    34 publications

    6.3K citations

  4. The University of Texas MD Anderson Cancer Center

    Houston, United States

    8 h-index

    27 publications

    5.3K citations

  5. Institute of Cancer Research

    London, United Kingdom

    8 h-index

    14 publications

    917 citations

  6. Cornell University

    Ithaca, United States

    7 h-index

    8 publications

    451 citations

  7. University of Bologna

    Bologna, Italy

    7 h-index

    18 publications

    278 citations

  8. University of Washington

    Seattle, United States

    6 h-index

    14 publications

    512 citations

1–8 of 646

Venues

  1. PubMed

    Repository · 62 publications · 3.2K citations

    30

    h-index

  2. Cancer

    18 publications · 1K citations

    16

    h-index

  3. Journal of Clinical Oncology

    18 publications · 1.7K citations

    16

    h-index

  4. PLoS ONE

    7 publications · 281 citations

    7

    h-index

  5. Cancer Chemotherapy and Pharmacology

    7 publications · 182 citations

    7

    h-index

1–5